Tyrosine-kinase inhibitor sorafenib (S) in treatment of metastatic renal cell carcinoma cancer (mRCC) with lung metastases.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e15611-e15611
Author(s):  
Irina L Popova ◽  
Liubov Yu Vladimirova ◽  
Natalya A Abramova
Keyword(s):  
Renal Cell Carcinoma ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Kinase Inhibitor ◽  
Lung Metastases

Metastatic renal cell carcinoma: how to make the best sequencing decision after withdrawal for intolerance to a tyrosine kinase inhibitor

2013 ◽  
Vol 9 (6) ◽  
pp. 831-843 ◽  
Author(s):  
Roberto Sabbatini ◽  
Cinizia Ortega ◽  
Giuseppe Procopio ◽  
Cristina Masini ◽  
Enzo Galligioni ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Kinase Inhibitor

scholarly journals Prediction of early progression of metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitor

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Jun Teishima ◽  
Daiki Murata ◽  
Shogo Inoue ◽  
Tetsutaro Hayashi ◽  
Koji Mita ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Kinase Inhibitor ◽  
First Line ◽  
Early Progression
Sign in / Sign up

Export Citation Format

Share Document